MRI-LINACs combine MRI and LINAC technologies with the potential for image guided radiation therapy with optimal soft-tissue contrast. In this work, we present the advantages and limitations of plastic scintillation dosimeters (PSDs) for relative dosimetry with MRI-LINACs. PSDs possess many desirable qualities, including magnetic field insensitivity and irradiation angle independence, which are expected to make them suitable for dosimetry with MRI-LINACs. An in-house PSD was used to measure field size output factors as well as a percent depth dose distribution and the beam quality index TPR20/10 at a [Formula: see text] cm2 field size. Measurements were repeated with a Scanditronix/Wellhofer FC65-G ionisation chamber and PTW 60019 microDiamond detector for comparison. Relative differences were calculated between the three detectors, where the mean difference in dose was 1.2% between the PSD and ionisation chamber, 1.9% between the PSD and microDiamond detector and 1.3% between the microDiamond detector and the ionisation chamber. The closeness between the three mean differences in doses suggests that PSDs are feasible for relative dosimetry with MRI-LINACs.
First measurements with a plastic scintillation dosimeter at the Australian MRI-LINAC
Introduction
MRI-Linear accelerators (MRI-LINACs) combine an MRIs optimal softtissue contrast and a modern LINACs highly conformal dose distributions to deliver image guided radiation therapy with non-invasive tumour tracking [1] .
For dosimetry with MRI-LINACs, the presence of the MRIs magnetic field alters the trajectories of charged particles traversing through the magnetic field and consequently the dose distributions delivered [2, 3, 4, 5] . The trajectory taken, and hence dose deposited by a charged particle in a volume of material is dependent on a materials density [2, 3] . Dosimeters with material densities not matching the density of water can have their accuracy compromised, however with correction they can be applied for MRI-LINAC dosimetry [6, 7] . Dosimeters that are minimally affected by magnetic fields are sought for MRI-LINAC dosimetry in conditions where the accuracy of other dosimeters may not be ensured [8, 9, 10] .
Plastic scintillation dosimeters (PSDs) consist of plastic scintillator volumes coupled to optical fibers and have numerous dosimetric qualities that suggest they are viable for MRI-LINAC dosimetry. In a recent study by Therriault-Proux et al. [9] , two PSDs were investigated to determine their magnetic field strength dependence. The PSDs responses increased by (2.4 ± 0.3)% and (2.4 ± 0.1)%, while Monte Carlo simulations in similar irradiation conditions reported a physical dose increase of 2.2% [6] . The authors attributed the PSDs increase in response to an increase in the physical dose deposited in the PSD, rather than changes in the PSDs sensitivity [9] . PSDs have also been shown to possess many desirable qualities for dosimetry with LINACs, including water equivalence [11, 12, 13] , energy independence for LINAC photon beams [14] , dose rate independence (i.e. a dose rate dependence less than 1%) [14, 15, 16] , irradiation angle independence [13, 14, 15] , high spatial resolutions [17, 18] and real time responses [11, 19] . PSDs have been used effectively for small field dosimetry [20, 21, 22] and in vivo dosimetry [23, 24, 25] with clinical LINACs. Given these qualities and their non-ferromagnetic composition, PSDs are promising prospects for MRI-LINAC dosimetry. The aim of this work was to apply and evaluate a PSD for relative dosimetry with an MRI-LINAC and present their advantages and limitations for relative dosimetry with MRI-LINACs.
Materials and Methods
The Australian MRI-LINAC project combines a 1 T open bore MRI scanner with a Varex Linatron-MP fitted with a Millenium 120 multileaf collimator (Varian, USA), shown in Figure 1 Cerenkov radiation generated in the optical fiber, a secondary fiber with no scintillator was used to measure the Cerenkov radiation produced in the PSD. This is known as background subtraction, and is considered the gold-standard in the field of PSD [11, 26] . A reference probe was constructed from an Eska was the cross calibration factor between the two PMTs. For background subtraction, the stem signal correction was performed by taking the PSD signal measured by one PMT, subtracting the reference probes signal multiplied by the cross calibration factor and integrating this difference in signals. A percent depth dose distribution was measured with all three dosimeters, shown in Figure 5 . Electron contamination from the LINAC is focused by an MRI-LINACs fringe field; for strong fringe fields like that at the Australian MRI-LINAC, this effect makes contaminant electrons deposit high doses at shallow depths in a narrow focal spot [4] . The normalisation depth for the presented Figure 4 : Output factor at 20 cm (top) and relative difference plot (bottom) as in Figure   3 . Error bars and nominal field size are as described in Figure 3 . IC, PSD and mD are as described for the relative difference plot in the caption for Figure 3 .
Results
PDD was chosen to be 50 mm instead of normalising the PDD to the response at 15 mm where electron contamination may be present. The microDiamond detector and ionisation chamber agreed (within error) at all depths except the 15 mm depth, where the differences in relative dose calculated between the microDiamond detector and ionisation chamber were of significantly smaller magnitude than the differences calculated with the PSD. The PSD remained in agreement (with error) with the ionisation chamber except at the 15 mm depth.
The beam quality index TPR 20/10 was measured at a field size of 10.5 × was measured to be 0.617 ± 0.013% by the PSD, while the ionisation chamber TPR 20/10 was measured to be 0.633 ± 0.011%.
Discussion
In Figure 3 , the disagreement between each detectors output factors at the smallest field size are attributed to multiple effects. The ionisation chamber had a total length and effective resolution of 2 cm; volume averaging potentially causes a reduction in the ionisation chamber response at the smallest field size.
At the smallest field size: 2.6 × 2.6 cm 2 , detector misalignment from the centre of field position may lead to a reduction in the dose delivered to the detector [30] ; each detector was aligned to isocentre with in-plane and cross-plane lasers by eye.
The electron focusing effect is known to produce a narrow lateral focal spot of electron contamination along the central axis of the photon beam [4] . Lateral volume averaging across the narrow focal spot may be a potential cause for the disagreements between each of the three detectors at the 15 mm depth. However, the alignment of each detector to the centre of the field was made by eye using for dosimetry with perpendicular orientation MRI-LINACs [31, 32] . However, the reported directional dependences of each detector are expected to be neg-ligible in the conditions where they were applied. For relative dosimetry with an MRI-LINAC, the ionisation chamber does not require correction for its directional dependence as any correction factor applied cancels out with itself [31] . For the perpendicular MRI-LINAC setup, the directional dependence of microDiamond reported by Woodings et al. [32] was 0.6% for a 0 • beam angle.
All measurements presented were made at the 0 • beam angle, however an inline MRI-LINAC setup was used for the presented measurements. The in-line MRI-LINAC setup used for the presented measurements was expected to reduce the magnitude of the microDiamond detectors directional dependence that was reported by Woodings et al. [32] . For the measurements made, the ionisation chamber and microDiamond detector are expected to be suitable references for the PSD.
From all presented relative differences in Figures 3-5 , the mean difference in dose was 1.2% between the PSD and ionisation chamber, 1.9% between the PSD and microDiamond detector and 1.3% between the microDiamond detector and the ionisation chamber. The overall standard deviation of the PSD was calculated by using the relative variations in the data from all experiments presented. The 95% confidence interval in the PSD was calculated to be 1.9%, corresponding to two standard deviations in the PSDs relative response. The corresponding 95% confidence interval in the microDiamond detectors response was calculated to be 1.8%, while the corresponding confidence interval for the ionisation chambers response was calculated to be 1.9%. The similar magnitudes in the mean differences in dose and confidence intervals for each detector suggest that the in-house PSD is as effective as the ionisation chamber and microDiamond detector.
Conclusion
An in-house PSD was used for the measurement of output factors, a PDD and TPR 20/10 at the Australian MRI-LINAC. The PSD was evaluated by comparing the measured distributions with those measured by an ionisation cham-ber (FC65-G, Scanditronix / Wellhofer) and a microdiamond detector (PTW 60019). Relative differences were calculated between the three detectors, where the mean difference in dose was 1.2% between the PSD and ionisation chamber, 1.9% between the PSD and microDiamond detector and 1.3% between the mi-croDiamond detector and the ionisation chamber. The reproducibility of each dosimeter relative response was calculated and the 95% confidence interval in the PSD, ionisation chamber and microdiamond were calculated to be 1.9%, 1.9% and 1.8%, respectively. The closeness between the three mean differences in dose and 95% confidence intervals suggests that the PSD was as viable as the ionisation chamber and microDiamond detector for relative dosimetry with an MRI-LINAC. As PSDs are known to possess irradiation angle independence and magnetic field insensitivity, the presented results supports that PSDs are effective for relative dosimetry with MRI-LINAC. 
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